日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial

Olutasidenib治疗复发/再发性局部晚期或转移性IDH1突变软骨肉瘤:1b/2期试验

Jones, Robin L; Groisberg, Roman; Blay, Jean-Yves; Colman, Howard; De La Fuente, Macarena; Roxburgh, Patricia; Chao, Mwe Mwe; Tian, Hua; Duffaud, Florence; Bahleda, Rastislav; Van Tine, Brian A

Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarker

肿瘤分数在晚期肉瘤预后中的意义:一种新型循环生物标志物的发现

Taleb, Sofiane; Brunet, Maxime; Belcaid, Laila; Bahleda, Ratislav; Verret, Benjamin; Cesne, Axel Le; Peyraud, Florent; Spalato-Ceruso, Mariella; Toulmonde, Maud; Italiano, Antoine

Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results

单核细胞谱系肿瘤浸润可预测晚期既往接受过治疗的软组织肉瘤的免疫放射治疗反应:II期临床试验结果

Levy, Antonin; Morel, Daphné; Texier, Matthieu; Rodriguez-Ruiz, Maria E; Bouarroudj, Lisa; Bouquet, Fanny; Bustillos, Alberto; Quevrin, Clément; Clémenson, Céline; Mondini, Michele; Meziani, Lydia; Sun, Roger; Zaghdoud, Nadia; Tselikas, Lambros; Assi, Tarek; Faron, Matthieu; Honoré, Charles; Ngo, Carine; Verret, Benjamin; Le Péchoux, Cécile; Le Cesne, Axel; Ginhoux, Florent; Massard, Christophe; Bahleda, Rastilav; Deutsch, Eric

Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab

利用抗血管生成药物重塑冷软组织肉瘤的肿瘤微环境:瑞戈非尼联合阿维鲁单抗的 II 期临床试验

Toulmonde, Maud; Guégan, Jean-Philippe; Spalato-Ceruso, Mariella; Valentin, Thibaud; Bahleda, Rastilav; Peyraud, Florent; Rey, Christophe; Kind, Michèle; Cantarel, Coralie; Bellera, Carine; Vanhersecke, Lucile; Bessede, Alban; Italiano, Antoine

Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics

多组学分析鉴定出两种具有不同信号传导和免疫特征的上皮样肉瘤分子亚型。

Ngo, Carine; Colmet-Daage, Léo; Vibert, Julien; Hénon, Clémence; Pissaloux, Daniel; Valent, Alexander; Xiang Jin, Jia; Brillet, Riwan; Masliah-Planchon, Julien; Pierron, Gaëlle; Lacroix, Ludovic; Rouleau, Etienne; Roussel-Simonin, Cyril; Lecorgne, Lilian; Astier, Clémence; Garrido, Marlène; Bahleda, Rastislav; Verret, Benjamin; Cesne, Axel Le; Honore, Charles; Faron, Matthieu; Herman Fridman, Wolf; Sautès-Fridman, Catherine; Coindre, Jean-Michel; Scoazec, Jean-Yves; Waterfall, Joshua J; Bourdeaut, Franck; Grünewald, Thomas G P; Blay, Jean-Yves; Tirode, Franck; Postel-Vinay, Sophie

Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX study

皮下注射纳武利尤单抗的药代动力学和安全性:来自 I/II 期 CheckMate 8KX 研究的结果

Lonardi, Sara; Ługowska, Iwona; O'Donnell, Anne; Jackson, Christopher; Latten-Jansen, Loes Maria; North, Richard; Bahleda, Rastislav; Garrido, Marcelo; Santoro, Armando; Chacon, Matías Rodrigo; Li, Linghui; Joseph, Devanand; Vezina, Heather E; Aras, Urvi; Bennett, Bryan; Perumal, Deepak; Gurm, Balmeet; Ng, Wee-Teck; Harvey, R Donald; Trigo, José; Calvo, Aitana

Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients

肛门鳞状细胞癌的全面分子图谱:对1844例患者的组织和液体活检样本的分析

Smolenschi, Cristina; Sisoudiya, Saumya D; Hollebecque, Antoine; Sivakumar, Smruthy; Montesion, Meagan; Euzen, Victor; Boige, Valérie; Boilève, Alice; Valery, Marine; Sourouille, Isabelle; Bayle, Arnaud; Aldea, Mihaela; Rodriguez, Julieta Elena; Gelli, Massimiliano; Dall'Olio, Filippo Gustavo; Tarabay, Anthony; Pudlarz, Thomas; Bahleda, Rastislav; Fuerea, Alina; Benhaim, Léonor; de Sevilla, Elena Fernandez; Bani, Mohamed; Dartigues, Peggy; Pernot, Simon; Boillet, Gautier; Beshiri, Kristi; Massard, Christophe; Friboulet, Luc; Facchinetti, Francesco; Lacroix, Ludovic; Rouleau, Etienne; Barlesi, Fabrice; Ducreux, Michel; Italiano, Antoine; Sharaf, Radwa; Vasseur, Damien

HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype

HuR 缺失会破坏 Foxp3 mRNA 的稳定性并损害调节性 T 细胞的功能,从而导致自身免疫表型。

Fattahi, Fatemeh; Ellis, Jason S; Vallance, Laura; Bahleda, Kristin; Holden, Julia; Socha, Sarah; Meier, Joshua; Gomez-Rivera, Francisco; Atasoy, Ulus

Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia

在针对复发或难治性非霍奇金淋巴瘤和B细胞慢性淋巴细胞白血病患者的I期首次人体临床试验中,使用crenigacestat (LY3039478)抑制Notch通路。

Michot, Jean-Marie; Balogh, Zsofia; Brown, Jennifer R; Ribrag, Vincent; Hollebecque, Antoine; Bahleda, Rastislav; Quivoron, Cyril; Ammari, Samy; Scoazec, Jean-Yves; Benhadji, Karim A; Massard, Christophe

Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023

2008年至2023年血液系统恶性肿瘤患者参与早期临床试验的相关性、风险和益处

Guerra, Matteo; Alouani, Emily; Hueso, Thomas; Ouali, Kaissa; Danu, Alina; Hollebecque, Antoine; Bahleda, Rastislav; Willekens, Christophe; Gazzah, Anas; Baldini, Capucine; Postel-Vinay, Sophie; Micol, Jean-Baptiste; Massard, Christophe; De Botton, Stéphane; Ribrag, Vincent; Michot, Jean-Marie